This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
InterCure Crescita futura
Future criteri di controllo 5/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for InterCure.
Informazioni chiave
46.6%
Tasso di crescita degli utili
n/a
Tasso di crescita dell'EPS
| Pharmaceuticals crescita degli utili | 54.9% |
| Tasso di crescita dei ricavi | 20.5% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Low |
| Ultimo aggiornamento | 19 May 2023 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2024 | 585 | 57 | N/A | N/A | 1 |
| 12/31/2023 | 470 | 15 | -18 | N/A | 2 |
| 3/31/2023 | 408 | 32 | -18 | -4 | N/A |
| 12/31/2022 | 389 | 45 | 32 | 51 | N/A |
| 9/30/2022 | 363 | 33 | -6 | 17 | N/A |
| 6/30/2022 | 324 | 24 | 4 | 24 | N/A |
| 3/31/2022 | 274 | 15 | 7 | 25 | N/A |
| 12/31/2021 | 220 | 5 | 16 | 30 | N/A |
| 9/30/2021 | 167 | 17 | 20 | 32 | N/A |
| 6/30/2021 | 128 | 20 | 12 | 25 | N/A |
| 3/31/2021 | 94 | 13 | 2 | 19 | N/A |
| 12/31/2020 | 65 | -37 | -13 | 8 | N/A |
| 9/30/2020 | 40 | -63 | -25 | -3 | N/A |
| 6/30/2020 | 20 | -80 | -42 | -16 | N/A |
| 3/31/2020 | 11 | -91 | -47 | -13 | N/A |
| 12/31/2019 | 9 | -6 | -40 | -12 | N/A |
| 9/30/2019 | 7 | 7 | -33 | -11 | N/A |
| 6/30/2019 | 5 | 18 | -18 | -5 | N/A |
| 3/31/2019 | 2 | 27 | -4 | -3 | N/A |
| 12/31/2018 | N/A | -13 | -2 | -1 | N/A |
| 9/30/2018 | N/A | -10 | -1 | -1 | N/A |
| 6/30/2018 | N/A | -8 | -1 | -1 | N/A |
| 3/31/2018 | N/A | -7 | -1 | -1 | N/A |
| 12/31/2017 | N/A | -6 | -1 | -1 | N/A |
| 9/30/2017 | N/A | -4 | -1 | -1 | N/A |
| 6/30/2017 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2017 | N/A | -2 | -1 | -1 | N/A |
| 12/31/2016 | N/A | 0 | N/A | -1 | N/A |
| 9/30/2016 | 0 | 0 | N/A | -1 | N/A |
| 6/30/2016 | 0 | -1 | N/A | -1 | N/A |
| 3/31/2016 | 1 | 0 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -2 | N/A | -2 | N/A |
| 9/30/2015 | 2 | -1 | N/A | -1 | N/A |
| 6/30/2015 | 3 | -2 | N/A | -1 | N/A |
| 3/31/2015 | 4 | -4 | N/A | -1 | N/A |
| 12/31/2014 | 6 | -4 | N/A | -2 | N/A |
| 9/30/2014 | 7 | -5 | N/A | -2 | N/A |
| 6/30/2014 | 7 | -5 | N/A | -2 | N/A |
| 3/31/2014 | 8 | -6 | N/A | -3 | N/A |
| 12/31/2013 | 8 | -7 | N/A | -3 | N/A |
| 9/30/2013 | 8 | -6 | N/A | -3 | N/A |
| 6/30/2013 | 8 | 43 | N/A | -3 | N/A |
| 3/31/2013 | 8 | 44 | N/A | -2 | N/A |
| 12/31/2012 | 8 | 43 | N/A | -2 | N/A |
| 9/30/2012 | 9 | 47 | N/A | -1 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: INCR.U's forecast earnings growth (46.6% per year) is above the savings rate (1.9%).
Guadagni vs Mercato: INCR.U's earnings (46.6% per year) are forecast to grow faster than the Canadian market (10.6% per year).
Guadagni ad alta crescita: INCR.U's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: INCR.U's revenue (20.5% per year) is forecast to grow faster than the Canadian market (6.2% per year).
Ricavi ad alta crescita: INCR.U's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if INCR.U's Return on Equity is forecast to be high in 3 years time